ES2979379T3 - Procedimiento para la preparación de compuesto de triaminopirimidina y productos intermedios del mismo - Google Patents
Procedimiento para la preparación de compuesto de triaminopirimidina y productos intermedios del mismo Download PDFInfo
- Publication number
- ES2979379T3 ES2979379T3 ES18778565T ES18778565T ES2979379T3 ES 2979379 T3 ES2979379 T3 ES 2979379T3 ES 18778565 T ES18778565 T ES 18778565T ES 18778565 T ES18778565 T ES 18778565T ES 2979379 T3 ES2979379 T3 ES 2979379T3
- Authority
- ES
- Spain
- Prior art keywords
- compound
- triaminopyrimidine
- crystalline form
- solvents
- crystalline
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
- A61P33/06—Antimalarials
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/73—Unsubstituted amino or imino radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IN201721031453 | 2017-09-05 | ||
| IN201721034342 | 2017-09-27 | ||
| PCT/IB2018/056732 WO2019049021A1 (en) | 2017-09-05 | 2018-09-04 | PROCESS FOR THE PREPARATION OF TRIAMINOPYRIMIDINE COMPOUND AND ITS INTERMEDIATES |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2979379T3 true ES2979379T3 (es) | 2024-09-25 |
Family
ID=63684213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES18778565T Active ES2979379T3 (es) | 2017-09-05 | 2018-09-04 | Procedimiento para la preparación de compuesto de triaminopirimidina y productos intermedios del mismo |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US12378223B2 (enExample) |
| EP (1) | EP3679030B1 (enExample) |
| JP (1) | JP2020532513A (enExample) |
| CN (1) | CN111051299A (enExample) |
| CA (1) | CA3071226A1 (enExample) |
| ES (1) | ES2979379T3 (enExample) |
| MX (2) | MX2020002142A (enExample) |
| PH (1) | PH12020500385A1 (enExample) |
| WO (1) | WO2019049021A1 (enExample) |
| ZA (1) | ZA202000903B (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025115034A1 (en) * | 2023-11-30 | 2025-06-05 | Zydus Lifesciences Limited | A process for the preparation of a triaminopyrimidine compound and novel intermediates thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RS58124B1 (sr) * | 2014-04-28 | 2019-02-28 | Medicines For Malaria Venture Mmv | Triaminopirimidin jedinjenja korisna za prevenciju ili tretman malarije |
-
2018
- 2018-09-04 EP EP18778565.4A patent/EP3679030B1/en active Active
- 2018-09-04 US US16/640,491 patent/US12378223B2/en active Active
- 2018-09-04 JP JP2020511759A patent/JP2020532513A/ja not_active Withdrawn
- 2018-09-04 CN CN201880055980.1A patent/CN111051299A/zh active Pending
- 2018-09-04 MX MX2020002142A patent/MX2020002142A/es unknown
- 2018-09-04 ES ES18778565T patent/ES2979379T3/es active Active
- 2018-09-04 CA CA3071226A patent/CA3071226A1/en active Pending
- 2018-09-04 WO PCT/IB2018/056732 patent/WO2019049021A1/en not_active Ceased
-
2020
- 2020-02-12 ZA ZA2020/00903A patent/ZA202000903B/en unknown
- 2020-02-25 MX MX2024002113A patent/MX2024002113A/es unknown
- 2020-02-27 PH PH12020500385A patent/PH12020500385A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ZA202000903B (en) | 2024-07-31 |
| EP3679030B1 (en) | 2024-03-27 |
| US12378223B2 (en) | 2025-08-05 |
| EP3679030A1 (en) | 2020-07-15 |
| JP2020532513A (ja) | 2020-11-12 |
| MX2024002113A (es) | 2024-03-06 |
| PH12020500385A1 (en) | 2020-12-07 |
| CN111051299A (zh) | 2020-04-21 |
| US20200207738A1 (en) | 2020-07-02 |
| CA3071226A1 (en) | 2019-03-14 |
| BR112020003557A2 (pt) | 2020-09-01 |
| WO2019049021A1 (en) | 2019-03-14 |
| MX2020002142A (es) | 2020-07-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2389565T3 (es) | Rosuvastatina y sales de la misma carentes de alquiléter de rosuvatatina y un procedimiento para la preparación de las mismas | |
| CA2958139A1 (en) | Solid state forms of ibrutinib | |
| EP3209652B1 (en) | Tricyclic atropisomer compounds | |
| CN104736540B (zh) | 培美曲塞及其赖氨酸盐的制备方法 | |
| JP6374436B2 (ja) | 純粋なエルロチニブ | |
| ES2879294T3 (es) | Formas polimórficas de Belinostat y procesos para la preparación de las mismas | |
| US10144708B2 (en) | Crystalline arylalkylamine compound and process for producing the same | |
| CN109384767B (zh) | 一种吡啶并嘧啶类衍生物的制备方法及其中间体 | |
| CA2996258A1 (en) | A process for the preparation of xylene linked cyclam compounds | |
| KR100878698B1 (ko) | 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및이를 포함하는 약학 조성물 | |
| US20180057503A1 (en) | Pharmaceutically Acceptable Salts and Polymorphic Forms of Hydrocodone Benzoic Acid Enol Ester and Processes for Making Same | |
| EP3679030B1 (en) | A process for preparation of triaminopyrimidine compound and intermediates thereof | |
| EP2414317A2 (en) | Palladium-catalyzed ortho-fluorination | |
| WO2020053795A2 (en) | Process for the preparation of acalabrutinib and its intermediates | |
| BR112020003557B1 (pt) | Formas cristalinas de um composto de triaminopirimidina, processos para a preparação do referido composto, composto de triaminopirimidina apresentando as referidas formas cristalinas e composições compreendendo o referido composto | |
| KR102793047B1 (ko) | 4-치환 옥사졸로퀴놀리논 유도체, 약학적으로 허용되는 이의 염인 화합물 및 이를 유효성분으로 포함하는 천식 또는 아토피 등의 알러지성 질환의 예방 또는 치료용 약학 조성물 | |
| CN114195800A (zh) | Usp7抑制剂 | |
| US9796677B2 (en) | Amide compound and pharmaceutical comprising same | |
| KR101307712B1 (ko) | 결정형의 베포타스틴 금속염 수화물, 이의 제조방법 및 이를 포함하는 약학 조성물 | |
| KR20200029751A (ko) | 보티옥세틴 니코티네이트 및 이의 제조방법 | |
| KR20190039087A (ko) | 정제된 세니크리비록 및 세니크리비록을 제조하기 위한 정제된 중간체 | |
| KR20160065496A (ko) | 페녹시피리미디논 유사체의 재결정을 통한 정제 방법 | |
| KR20200068667A (ko) | 고체 형태의 스테모스피로닌 및 이의 염 | |
| KR100267059B1 (ko) | 3-비닐퀴놀린 유도체 및 약학적으로 허용되는 그의 염 | |
| TW202408515A (zh) | 含有kras g12c抑制劑及奧諾拉(aurora)a抑制劑之治療方法 |